Literature DB >> 2556900

In vitro effects of leukotriene B4 (LTB4) on canine PMN effector function(s).

D F Gruber1, M M D'Alesandro, T L Walden.   

Abstract

The canine has become an accepted research model for the examination of a number of human clinical conditions. Despite it's status as a research model, little is known regarding the peripheral effects of inflammatory mediator substances. Products of arachidonic acid metabolism (leukotrienes) are reported capable of altering leukocyte functions. Because of the emerging importance of the canine research model and leukotrienes we examined the effects of leukotriene B4 (LTB4) on several in vitro functions of isolated canine peripheral polymorphonuclear leukocytes (PMN). Changes in forward angle light scatter properties of the cells were used as one measure of PMN activation. Other functional changes examined following LTB4 pretreatment included chemotactic capability, the electrophysiological state of the cell plasma membrane, and the metabolic oxidative response (i.e. H2O2 production). Random cellular movement of PMNs increased by 120% and 72% following preincubation with 10(-7) and 10(-9) M LTB4, respectively. LTB4 between 10(-7) and 10(-13) M did not significantly alter cellular resting membrane potential. Between 10(-7) and 10(-9) M LTB4 elicited significant levels of cellular H2O2 production. Although significant, H2O2 production was less than 40% that induced by phorbol myristate acetate (PMA). In numerous respects, canine in vitro PMN responses parallel previous reports of human cell function(s) in the presence of inflammatory mediators and may represent an attractive alternative for investigation of PMN dysfunctions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556900     DOI: 10.1007/BF01967412

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  35 in total

1.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

2.  Leukotriene B4: an inflammatory mediator in vivo.

Authors:  M A Bray; A W Ford-Hutchinson; M J Smith
Journal:  Prostaglandins       Date:  1981-08

3.  Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.

Authors:  G D Gray; G M Ohlmann; D R Morton; R G Schaub
Journal:  Agents Actions       Date:  1986-06

4.  Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.

Authors:  D E Feltner; R H Smith; W A Marasco
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

5.  Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.

Authors:  P Bhattacherjee; B Hammond; J A Salmon; R Stepney; K E Eakins
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

6.  Aggregation, chemotaxis, and chemiluminescence of canine granulocytes. Studies utilizing improved cell preparation techniques.

Authors:  H Redl; P J Flynn; H Lamche; A Schiesser; G Schlag; D E Hammerschmidt
Journal:  Inflammation       Date:  1983-03       Impact factor: 4.092

7.  Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).

Authors:  R Huey; T E Hugli
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

8.  Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

9.  Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.

Authors:  D W Goldman; E J Goetzl
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

10.  Functional characterization of synthetic leukotriene B and its stereochemical isomers.

Authors:  R A Lewis; E J Goetzl; J M Drazen; N A Soter; K F Austen; E J Corey
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.